|
MX2018013893A
|
|
Stable topical composition.
|
|
MX2017016978A
|
|
A pharmaceutical composition for low molecular weight heparins.
|
|
MX2017011814A
|
|
A formulation including stable supramolecular complexes.
|
|
MX2016017001A
|
|
Multiparticulated biphasic release system with enhanced bioavailability predictive of acematacine.
|
|
US2017281640A1
|
|
Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)
|
|
MX2013002767A
|
|
Highly permeable pharmaceutical composition containing a selective inhibitor of cyclooxygenase 2.
|
|
MX2010003532A
|
|
Pharmaceutical combination with anti-migraine effect, in solid presentation of extended release.
|
